News ArticleCoal India Limited Declares Rs. 10.25 Per Share 2nd Interim Dividend for H1 FY 2026-27 with Unaudited Q2 Financials
Board sets record date as November 4, 2026 for the dividend; payment scheduled on or before November 27, 2026
Coal India Limited reported its unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026. The Board declared a 2nd interim dividend of Rs. 10.25 per equity share for FY 2026-27, payable by November 27, 2026, with record date set to November 4, 2026.
Coal India Limited
Financial Results
Coal India Limited announced its unaudited standalone and consolidated financial results for Q2 and H1 of FY 2026-27 and declared a 2nd interim dividend of Rs. 10.25 per equity share of Rs. 10 face value.
The Board of Directors approved the financial results for the quarter and half year ended September 30, 2026, after review by the Audit Committee.
The 2nd interim dividend is declared as recommended by the Audit Committee in its October 29, 2026 meeting.
The company has fixed Wednesday, November 4, 2026, as the record date for determining the eligibility of shareholders for the dividend payment.
The dividend will be paid on or before November 27, 2026.
In compliance with SEBI (LoDR) Fifth Amendment Regulations 2025, Coal India will disburse dividends only via RBI-approved electronic transfer methods, with no physical warrants or cheques issued.
Highlights
- 2nd interim dividend declared at Rs. 10.25 per equity share of Rs. 10 face value.
- Record date fixed on November 4, 2026.
- Dividend payment scheduled on or before November 27, 2026.
- Unaudited financial results for Q2 and H1 FY 2026-27 reported.
- Dividend payments will be made electronically as per SEBI regulations.
Key Data Snapshot
What happened
- Coal India Limited declared its 2nd interim dividend of Rs. 10.25 per equity share for FY 2026-27.
- Unaudited financial results for the second quarter and half year ended September 30, 2026, were approved.
- Dividend record date set as November 4, 2026.
- Dividend payments will be made electronically only, aligning with SEBI regulations.
Key details
- Dividend is based on a face value of Rs. 10 per equity share.
- Dividend payment to shareholders will be completed on or before November 27, 2026.
- SEBI (LoDR) (Fifth Amendment) Regulations, 2025 require dividend payments through RBI approved electronic modes only.
- Shareholders need to update their KYC details with depository participants to facilitate direct electronic dividend transfers.
Regulatory and governance context
- Dividend declaration and financial results comply with SEBI Listing Regulations 2015 (Regulation 30 and 33).
- The Audit Committee reviewed the financial results and recommended the dividend.
- Board of Directors approved the dividend and unaudited financial results on October 29, 2026.
- Dividend disbursement mode changed as per SEBI (LoDR) (Fifth Amendment) Regulations, 2025 effective from November 18, 2025.
Highlights
- 2nd interim dividend declared at Rs. 10.25 per equity share of Rs. 10 face value.
- Record date fixed on November 4, 2026.
- Dividend payment scheduled on or before November 27, 2026.
- Unaudited financial results for Q2 and H1 FY 2026-27 reported.
- Dividend payments will be made electronically as per SEBI regulations.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- SEBI (LoDR) (Fifth Amendment) Regulations, 2025
Source Information
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Indegene Limited Announces Unaudited Consolidated and Standalone Results for Q2 and H1 Ending September 30, 2026
Indegene Limited approved its unaudited consolidated and standalone financial results for the second quarter and half year ended September 30, 2026, alongside approving allotments under RSU and ESOP schemes and key personnel resignations during its board meeting on October 29, 2026.
Read Full Story
Alivus Life Sciences Posts ₹3,568 Million Net Profit in First Half of FY2026, Q2 Net Profit at ₹1,967 Million
Alivus Life Sciences Limited has reported its unaudited financial results for the second quarter and half year ended September 30, 2026, posting a net profit of ₹1,967 million for the quarter and ₹3,568 million for the half year, supported by revenue growth.
Read Full Story
Timken India Limited Achieves Rs 2,311.94 Million Net Profit for First Half of FY 2026-27
Timken India Limited reported a net profit after tax of Rs 2,311.94 million for the half year ended September 30, 2026, with revenue from operations totaling Rs 18,983.82 million, as per its unaudited standalone financial results approved by the Board on October 29, 2026.
Read Full Story
